TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,207 | +171.6% | 789 | +175.9% | 0.00% | – |
Q2 2023 | $4,494 | -4.7% | 286 | 0.0% | 0.00% | – |
Q1 2023 | $4,714 | -22.7% | 286 | -26.9% | 0.00% | – |
Q4 2022 | $6,100 | +52.5% | 391 | +36.7% | 0.00% | – |
Q3 2022 | $4,000 | 0.0% | 286 | 0.0% | 0.00% | – |
Q2 2022 | $4,000 | 0.0% | 286 | 0.0% | 0.00% | – |
Q1 2022 | $4,000 | -71.4% | 286 | -72.3% | 0.00% | – |
Q4 2021 | $14,000 | -17.6% | 1,031 | 0.0% | 0.00% | – |
Q3 2021 | $17,000 | 0.0% | 1,031 | 0.0% | 0.00% | – |
Q2 2021 | $17,000 | -10.5% | 1,031 | -1.0% | 0.00% | -100.0% |
Q1 2021 | $19,000 | 0.0% | 1,041 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $19,000 | 0.0% | 1,041 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $19,000 | 0.0% | 1,041 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $19,000 | +18.8% | 1,041 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $16,000 | -36.0% | 1,041 | -19.4% | 0.00% | 0.0% |
Q4 2019 | $25,000 | -55.4% | 1,292 | -60.5% | 0.00% | -50.0% |
Q3 2019 | $56,000 | -30.0% | 3,273 | -27.4% | 0.00% | -33.3% |
Q2 2019 | $80,000 | – | 4,509 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |